Feed HROW
HR
Harrow Health, Inc.
HROW · NASDAQ
$43.71 -0.66% (-$0.29)
1M +10.00%
Market Cap $1.6B
P/E Ratio -
Div. Yield -
ROE 33.79%
Bulios Fair Price
$102.02
133.4% upside
Trenutna cena
$43.71
Podcenjeno Poštena vrednost Precenjeno
Valuation
2 /100
Expensive P/B 57.47x
EV/EBITDA 86.91x
P/FCF 36.86x
Growth
100 /100
Growing Book val. growth 23.87%
Rev. growth 45.39%
FCF growth N/A
Profitability
43 /100
Moderate Op. margin 7.32%
Gross margin 74.11%
FCF margin 16.45%
Quality
7 /100
Poor ROA 0.00%
ROIC 4.77%
Asset turnover 0.64x
Debt
18 /100
High Int. coverage 2.66x
Debt/Equity 10.61x
Net debt/EBITDA 9.76x
Stability
23 /100
Unstable EPS volatility 60.65%
Beta 0.26x
Profitable years 0
Vprašajte StockBota o HROW
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mark L. Baum
Employees
373
Headquarters
Nashville
Prihajajoči dogodki
10 AVG.
Earnings
Upcoming earnings report